Tag: anti-sclerostin therapy
Multiple Myeloma: Understanding Bone Disease and the New Drugs Changing Outcomes
Multiple myeloma causes severe bone damage in over 80% of patients. New drugs like romosozumab and DKN-01 are now showing promise in healing bone lesions, not just preventing them. Learn how these novel agents are changing treatment.
VIEW MORE